Biacore AB
Global supplier of systems for protein interaction analysis
Biacore AB is a GE Healthcare company.
Erik Walldén (President, CEO)
Rapsgatan 7
SE-754 50
Uppsala
Sweden
Phone: +46 (0)18 675 700
Fax: +46 (0)18 675 811
Label-free interaction analysis is of increasing importance for scientists in the academic, pharmaceutical, biotechnology and diagnostic markets. Setting the performance benchmark, Biacore™ systems generate unique data on the interactions between proteins and other molecules, including small molecule drug candidates. During research, development and manufacture, these data give insights into protein functionality, elucidate disease mechanisms and play a key role in the critical decisions needed for efficient development and production of therapeutics.
Biacore systems are used in areas such as pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture, and many life science research applications. A range of systems meet specific application needs. Customers include leading research centers, all of the leading global pharmaceutical companies, and many biotechnology companies.
In the food analysis market, a system and ready-to-use kits provide key manufacturers with the ability to determine quality and safety in areas such as quantification of vitamin content and screening for veterinary drug residues.
Related patents
- Assay method based upon refractive index changes at a solid optical surface
- Valve, especially for fluid handling bodies with microflow channels
- Method of assaying for an analyte using surface plasmon resonance
- Milk assay
- Pathogen assay method
- Surface plasmon resonance-mass spectrometry
- Method of producing bilayer lipid membranes
- Analyte detection
- Method and system for analyte determination
- Analytical method and apparatus
- Analytical method and apparatus
- Surface-sensitive detection of hybridization at equilibrium
- Monitoring of refractive index of optical sensor for determination of surface structure changes
- Method for nucleic acid analysis
- Method of determining affinity or kinetic properties in solution
- Surface regeneration of biosensors
- Method and system for analyte determination
- Analytical method and apparatus
- Reversible-flow conduit system
- Reversible-flow conduit system
- Method and apparatus for assaying a drug candidate to estimate a pharmacokinetic parameter associated therewith
- Method and kit for detecting betalactam-containing compounds
- Analytical method and apparatus
- Analytical method and apparatus
- Valve integrally associated with microfluidic liquid transport
- Cover for a measuring cassette for biosensor apparatus
- Method of preparing supported lipid film membranes and use thereof
- Apparatus and method for total internal reflection spectroscopy
- Flow cell method
- Analytical method and apparatus
- Method for capturing analytes eluted from surface-bound ligands
- Method and system for curve quality control
- Method of coupling binding agents to a substrate surface
- Assay with co-immobilized ligands
- Valve integrally associated with microfluidic liquid transport assembly
- Method of determining site-specificity and kit therefor
- Analytical method and apparatus
- Immobilization method and kit therefor
- Method and kit for cell analyte assay
- Method and system for determination of molecular interaction parameters
- Method and apparatus for characterization of interactions
- Apparatus and method for total internal reflection spectroscopy
- Method and system for interaction analysis
- Method and apparatus for assaying a drug candidate to estimate a pharmacokinetic parameter associated therewith
- Method and apparatus for the development of a control process for an instrument
- Sample flow positioning method and analytical system using the method
- Immobilization method and kit therefor
- Method and kit for cell analyte assay
Related news
- Biomedical Diagnostics Institute Purchases Biacore A100 Label-free Protein Interaction Analysis System for Development of Novel Clinical Diagnostics
- Biacore System Used in Study to Show Potential Drug Target for Sleeping Sickness Causing Parasites
- Biacore to Host DiPIA 2007 Conference in Phoenix, Arizona, May 6-9, Pointe Hilton Squaw Peak Resort
- Launch Of Biacore X100 Brings Protein Interaction Analysis Within Reach Of Every Life Science Research Lab
- Biacore to Announce Extraordinary General Meeting September 7, 2006
- Biacore International AB to Decide About Extra Shareholders Meeting and Application for Delisting
- Biacore International AB Will Release its Half-Year Report January-June
- Biacore Launches its Own Operation in China
- Annual General Meeting of Shareholders in Biacore International AB
- Biacore to Publish Conference Call Regarding Interim Report January-March 2006
- Biacore First Quarter Sales Update
- Biacore International AB to an Annual General Meeting of Shareholders on May 4, 2006.
- The Biacore Board Proposes a New Long Term Incentive Program
- Biacore to Publish Year-End Report
- Biacore International AB will release its Year-end report 2005 on Thursday,
